KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$1.44
-0.06 (-4.00%)
Open$1.49
Previous Close$1.50
Day High$1.51
Day Low$1.40
52W High$2.91
52W Low$1.48
Volume—
Avg Volume106.2K
Market Cap6.46M
P/E Ratio—
EPS$-2.47
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,937.5% upside
Current
$1.44
$1.44
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.53M | 8.57M | 1.95M |
| Net Income | 3.48M | 1.73M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 4.31M | 2.26M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |